VitaSpring Biomedical Co. Ltd. (VSBC)
- Previous Close
15.00 - Open
15.00 - Bid --
- Ask --
- Day's Range
15.00 - 15.00 - 52 Week Range
13.10 - 16.00 - Volume
200 - Avg. Volume
0 - Market Cap (intraday)
3.098B - Beta (5Y Monthly) 1.17
- PE Ratio (TTM)
∞ - EPS (TTM)
0.00 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
VitaSpring Biomedical Co. Ltd. focuses on the development of drugs of cell medicine. The company was formerly known as Shemn Corp. and changed its name to VitaSpring Biomedical Co. Ltd. in February 2020. VitaSpring Biomedical Co. Ltd. was incorporated in 2016 and is headquartered in Irvine, California.
www.vitaspringbio.comRelated News
Performance Overview: VSBC
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VSBC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VSBC
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
663.71
Enterprise Value/EBITDA
2.77k
Financial Highlights
Profitability and Income Statement
Profit Margin
18.79%
Return on Assets (ttm)
40.98%
Return on Equity (ttm)
84.16%
Revenue (ttm)
4.98M
Net Income Avi to Common (ttm)
935.61k
Diluted EPS (ttm)
0.00
Balance Sheet and Cash Flow
Total Cash (mrq)
24.05k
Total Debt/Equity (mrq)
19.61%
Levered Free Cash Flow (ttm)
-481.1k
Company Insights: VSBC
VSBC does not have Company Insights